On August 10, 2018, Aralez Pharmaceuticals US Inc. and 6 affiliated debtors (collectively, the "Debtors") each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York. The cases are pending before the Honorable Martin Glenn and are jointly administered under Case No. 18-12425.
Plan & Disclosure Statement
On February 5, 2019, the Debtors filed their Plan of Liquidation and the Disclosure Statement related thereto. The Bankruptcy Court will hold a hearing to consider approval of the Disclosure Statement on March 7, 2019 at 11:00 a.m.(ET).
Deadline to File Claims
The Bankruptcy Court has set the following deadlines for filing proofs of claim against the Debtors:
- General Bar Date (all creditors other than Governmental Units): November 29, 2018 at 5:00 p.m. (ET)
- Governmental Unit Bar Date: February 6, 2019 at 5:00 p.m. (ET)
Click on "Submit a Claim" above to download a proof of claim form and for more information regarding filing a claim against the Debtors.
Hearing on First Day Motions
A hearing on the Debtors' First Day Motions was held on August 13, 2018 at 11:00 a.m. (ET) before the Honorable Martin Glenn, United States Bankruptcy Court for the Southern District of New York, One Bowling Green, Courtroom 523, New York, New York 10004. A final hearing on certain of the First Day Motions was held on September 13, 2018 at 10:00 a.m.
Please click below to view and download the Debtors' First Day Motions and Orders:
Dislosure Statement Hear...
First Day Hearing
Final Hearing on First Day Motions
General Bar Date
Governmental Unit Bar Date
Dislosure Statement Hearing
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019
Paul V. Shalhoub
Debra C. McElligott
United States Trustee and Court Information
Office of the United States Trustee
U.S. Federal Office Building
201 Varick Street, Suite 1006
New York, NY 10014
Andrea B. Schwartz
United States Bankruptcy Court
Southern District of New York
One Bowling Green
New York, NY 10004-1408
|18-12425||Aralez Pharmaceuticals US Inc.||August 10, 2018|
|18-12426||Aralez Pharmaceuticals Holdings Limited||August 10, 2018|
|18-12427||Aralez Pharmaceuticals Management Inc.||August 10, 2018|
|18-12431||POZEN Inc.||August 10, 2018|
|18-12429||Aralez Pharmaceuticals Trading Designated Activity Company||August 10, 2018|
|18-12430||Halton Laboratories LLC||August 10, 2018|
|18-12428||Aralez Pharmaceuticals R&D Inc.||August 10, 2018|